Study of TAS-102 in Patients With Metastatic Colorectal Cancer Refractory to Standard Chemotherapies (Q63842442)
Jump to navigation
Jump to search
clinical trial
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Study of TAS-102 in Patients With Metastatic Colorectal Cancer Refractory to Standard Chemotherapies |
clinical trial |
Statements
RECOURSE (English)
0 references
Randomized, Double-blind, Phase 3 Study of TAS-102 Plus Best Supportive Care (BSC) Versus Placebo Plus BSC in Patients With Metastatic Colorectal Cancer Refractory to Standard Chemotherapies (English)
0 references
17 June 2012
0 references
24 January 2014
0 references
800
0 references
18 year
0 references